Literature DB >> 16794575

Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange.

Antony W Oliver1, Angela Paul, Katherine J Boxall, S Elaine Barrie, G Wynne Aherne, Michelle D Garrett, Sibylle Mittnacht, Laurence H Pearl.   

Abstract

The protein kinase Chk2 (checkpoint kinase 2) is a major effector of the replication checkpoint. Chk2 activation is initiated by phosphorylation of Thr68, in the serine-glutamine/threonine-glutamine cluster domain (SCD), by ATM. The phosphorylated SCD-segment binds to the FHA domain of a second Chk2 molecule, promoting dimerisation of the protein and triggering phosphorylation of the activation segment/T-loop in the kinase domain. We have now determined the structure of the kinase domain of human Chk2 in complexes with ADP and a small-molecule inhibitor debromohymenialdisine. The structure reveals a remarkable dimeric arrangement in which T-loops are exchanged between protomers, to form an active kinase conformation in trans. Biochemical data suggest that this dimer is the biologically active state promoted by ATM-phosphorylation, and also suggests a mechanism for dimerisation-driven activation of Chk2 by trans-phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794575      PMCID: PMC1500991          DOI: 10.1038/sj.emboj.7601209

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation.

Authors:  P Chen; C Luo; Y Deng; K Ryan; J Register; S Margosiak; A Tempczyk-Russell; B Nguyen; P Myers; K Lundgren; C C Kan; P M O'Connor
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Discriminating between homodimeric and monomeric proteins in the crystalline state.

Authors:  H Ponstingl; K Henrick; J M Thornton
Journal:  Proteins       Date:  2000-10-01

3.  Determination of substrate specificity and putative substrates of Chk2 kinase.

Authors:  Gil-Ju Seo; Se-Eun Kim; Young-Man Lee; Jeong-Won Lee; Jae-Rin Lee; Myong-Joon Hahn; Seong-Tae Kim
Journal:  Biochem Biophys Res Commun       Date:  2003-05-02       Impact factor: 3.575

Review 4.  The DNA damage response: sensing and signaling.

Authors:  Clare H McGowan; Paul Russell
Journal:  Curr Opin Cell Biol       Date:  2004-12       Impact factor: 8.382

Review 5.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

6.  Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.

Authors:  S Matsuoka; G Rotman; A Ogawa; Y Shiloh; K Tamai; S J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 7.  Targeting chk2 kinase: molecular interaction maps and therapeutic rationale.

Authors:  Yves Pommier; Olivier Sordet; V Ashutosh Rao; Hongliang Zhang; Kurt W Kohn
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

8.  Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine.

Authors:  Vasudha Sharma; Jetze J Tepe
Journal:  Bioorg Med Chem Lett       Date:  2004-08-16       Impact factor: 2.823

Review 9.  Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor.

Authors:  Clare H McGowan
Journal:  Bioessays       Date:  2002-06       Impact factor: 4.345

10.  Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation.

Authors:  Julie K Schwarz; Christine M Lovly; Helen Piwnica-Worms
Journal:  Mol Cancer Res       Date:  2003-06       Impact factor: 5.852

View more
  62 in total

1.  Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy.

Authors:  George T Lountos; Andrew G Jobson; Joseph E Tropea; Christopher R Self; Guangtao Zhang; Yves Pommier; Robert H Shoemaker; David S Waugh
Journal:  J Struct Biol       Date:  2011-09-22       Impact factor: 2.867

2.  Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly.

Authors:  Michael J Isaacs; Yasuhiko Kawakami; George P Allendorph; Byung-Hak Yoon; Juan Carlos Izpisua Belmonte; Senyon Choe
Journal:  Mol Endocrinol       Date:  2010-05-19

Review 3.  Kinase regulation of Na+-K+-2Cl- cotransport in primary afferent neurons.

Authors:  Eric Delpire; Thomas M Austin
Journal:  J Physiol       Date:  2010-05-24       Impact factor: 5.182

4.  Genetic interaction of RAD53 protein kinase with histones is important for DNA replication.

Authors:  Teresa M Holzen; Robert Sclafani
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

5.  Auto-activation mechanism of the Mycobacterium tuberculosis PknB receptor Ser/Thr kinase.

Authors:  Carl Mieczkowski; Anthony T Iavarone; Tom Alber
Journal:  EMBO J       Date:  2008-11-13       Impact factor: 11.598

6.  Calcium-binding protein 39 facilitates molecular interaction between Ste20p proline alanine-rich kinase and oxidative stress response 1 monomers.

Authors:  José Ponce-Coria; Kenneth B Gagnon; Eric Delpire
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

7.  Crystal structure of domain-swapped STE20 OSR1 kinase domain.

Authors:  Seung-Jae Lee; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

8.  Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor.

Authors:  George T Lountos; Joseph E Tropea; Di Zhang; Andrew G Jobson; Yves Pommier; Robert H Shoemaker; David S Waugh
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

9.  Myosin 3A kinase activity is regulated by phosphorylation of the kinase domain activation loop.

Authors:  Omar A Quintero; William C Unrath; Stanley M Stevens; Uri Manor; Bechara Kachar; Christopher M Yengo
Journal:  J Biol Chem       Date:  2013-11-10       Impact factor: 5.157

10.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.